Occurrence and Severity of Donor Lymphocyte Infusion–Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Authors:
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (5) , 912-920
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81530046)
- National Natural Science Foundation of China (81621001)
This publication has 43 references indexed in Scilit:
- Long‐term follow‐up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemiaCancer, 2012
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus CriteriaBlood, 2011
- Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisitedCancer Treatment Reviews, 2010
- Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHDBone Marrow Transplantation, 2009
- Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable with Unrelated Donor Transplantation for Patients with Hematologic MalignanciesClinical Cancer Research, 2009
- Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effectBone Marrow Transplantation, 2009
- Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow TransplantationTransplantation and Cellular Therapy, 2009
- Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI aloneBlood, 2007
- Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesBone Marrow Transplantation, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005